Recommendation for the Paul Ramsey Award for Excellence in Bioethics to Dr. Theresa Deisher
Recommendation for the Paul Ramsey Award for Excellence in Bioethics to Dr. Theresa Deisher.
We want to recommend Dr. Theresa Deisher for this award, not for her amply demonstrated scientific excellence in molecular and cellular physiology in a profession where there are many such experts and inventors, nor for her leadership in commercial bio-tech firms, with 23 patents to her credit, but rather for her outstanding moral courage and resolve. In the face of a very hostile government/bio-tech industry uniformly in favor of embryonic stem cell research, she energetically opposed the use of aborted human fetal remains in scientific investigation and in the production of vaccines.
She has publically fought such investigation and production before many audiences: for example, at the Minnesota Legislature (28 April 2011), in the Sherley vs Sibelius lawsuit in Federal court regarding stem cell funding (Dickey-Wicker Amendment), during interviews on radio programs, and in a professional contribution at the International Meeting for Autism Research in Philadelphia, PA May 20-22, 2010. She statistically revealed the incidence between the use of aborted fetal cell lines in the production of vaccines and the worldwide increase in Autism and Autism Spectrum Disorder.
In order to undertake her plan to introduce morally unobjectionable biological products, she left a high-level position in a bio-tech firm and founded AVM Biotechnology and its non-profit arm Sound Choice Pharmaceutical Institute. Her quarterly newsletter to the general public contains in-depth information on her achievements. Click on link to access a recent statement from Sound Choice Pharmaceutical Institute regarding its efforts in the area of research into the influence of aborted fetal DNA contaminants on auto-immune responses and on genomic instability, with special reference to Autism. With reference to embryonic stem cell research, there has been a great change of opinion in the bio-tech field, especially evidenced by the Geron´s abandoning of its work in embryonic stem cell research and therapy, announced in December 2011. Dr. Deisher´s “crusade” in favor of ethical adult stem cell research, as some have called it, will certainly deserve a large part of the credit.